Literature DB >> 25151457

Osteopontin expression in acute immune response mediates hippocampal synaptogenesis and adaptive outcome following cortical brain injury.

Julie L Chan1, Thomas M Reeves1, Linda L Phillips2.   

Abstract

Traumatic brain injury (TBI) produces axotomy, deafferentation and reactive synaptogenesis. Inflammation influences synaptic repair, and the novel brain cytokine osteopontin (OPN) has potential to support axon regeneration through exposure of its integrin receptor binding sites. This study explored whether OPN secretion and proteolysis by matrix metalloproteinases (MMPs) mediate the initial degenerative phase of synaptogenesis, targeting reactive neuroglia to affect successful repair. Adult rats received unilateral entorhinal cortex lesion (UEC) modeling adaptive synaptic plasticity. Over the first week postinjury, hippocampal OPN protein and mRNA were assayed and histology was performed. At 1-2d, OPN protein increased up to 51 fold, and was localized within activated, mobilized glia. OPN transcript also increased over 50 fold, predominantly within reactive microglia. OPN fragments known to be derived from MMP proteolysis were elevated at 1d, consistent with prior reports of UEC glial activation and enzyme production. Postinjury minocycline immunosuppression attenuated MMP-9 gelatinase activity, which was correlated with the reduction of neutrophil gelatinase-associated lipocalin (LCN2) expression, and reduced OPN fragment generation. The antibiotic also attenuated removal of synapsin-1 positive axons from the deafferented zone. OPN KO mice subjected to UEC had similar reduction of hippocampal MMP-9 activity, as well as lower synapsin-1 breakdown over the deafferented zone. MAP1B and N-cadherin, surrogates of cytoarchitecture and synaptic adhesion, were not affected. OPN KO mice with UEC exhibited time dependent cognitive deficits during the synaptogenic phase of recovery. This study demonstrates that OPN can mediate immune response during TBI synaptic repair, positively influencing synapse reorganization and functional recovery.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25151457      PMCID: PMC4262258          DOI: 10.1016/j.expneurol.2014.08.015

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  121 in total

1.  Expression of matrix metalloproteinases in the neurogenic niche of the adult monkey hippocampus after ischemia.

Authors:  Li Lu; Anton B Tonchev; Desislav B Kaplamadzhiev; Nadezhda B Boneva; Yoshimi Mori; Shunya Sahara; Dexuan Ma; Masa-aki Nakaya; Mitsuru Kikuchi; Tetsumori Yamashima
Journal:  Hippocampus       Date:  2008       Impact factor: 3.899

Review 2.  Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets.

Authors:  Iryna M Ethell; Douglas W Ethell
Journal:  J Neurosci Res       Date:  2007-10       Impact factor: 4.164

Review 3.  Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.

Authors:  Marta Scatena; Lucy Liaw; Cecilia M Giachelli
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-23       Impact factor: 8.311

4.  An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.

Authors:  V Takafuji; M Forgues; E Unsworth; P Goldsmith; X W Wang
Journal:  Oncogene       Date:  2007-04-23       Impact factor: 9.867

5.  Agrin expression during synaptogenesis induced by traumatic brain injury.

Authors:  M Cristina Falo; Thomas M Reeves; Linda L Phillips
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

6.  Osteopontin is extensively expressed by macrophages following CNS demyelination but has a redundant role in remyelination.

Authors:  Chao Zhao; Stephen P J Fancy; Charles ffrench-Constant; Robin J M Franklin
Journal:  Neurobiol Dis       Date:  2008-05-04       Impact factor: 5.996

7.  FK506-protective effects against trimethyltin neurotoxicity in rats: hippocampal expression analyses reveal the involvement of periarterial osteopontin.

Authors:  M Morita; H Imai; Y Liu; X Xu; M Sadamatsu; R Nakagami; T Shirakawa; K Nakano; Y Kita; K Yoshida; K Tsunashima; N Kato
Journal:  Neuroscience       Date:  2008-02-20       Impact factor: 3.590

8.  Characterization of osteopontin expression and function after status epilepticus.

Authors:  Karin Borges; Marla Gearing; Susan Rittling; Esben S Sorensen; Robert Kotloski; David T Denhardt; Raymond Dingledine
Journal:  Epilepsia       Date:  2008-06-03       Impact factor: 5.864

9.  The genomic profile of the cerebral cortex after closed head injury in mice: effects of minocycline.

Authors:  Peter J Crack; Jodee Gould; Nicole Bye; Shelley Ross; Uğur Ali; Mark D Habgood; Cristina Morganti-Kossman; Norman R Saunders; Paul J Hertzog
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

10.  Differential regulation of osteopontin receptors, CD44 and the alpha(v) and beta(3) integrin subunits, in the rat hippocampus following transient forebrain ischemia.

Authors:  Wha-Sun Kang; Jeong-Sun Choi; Yoo-Jin Shin; Ha-Young Kim; Jung-Ho Cha; Ji-Yeon Lee; Myung-Hoon Chun; Mun-Yong Lee
Journal:  Brain Res       Date:  2008-07-03       Impact factor: 3.252

View more
  24 in total

1.  Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.

Authors:  Thomas M Reeves; Patricia A Trimmer; Beverly S Colley; Linda L Phillips
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

2.  Patterns of Osteopontin Expression in Abusive Head Trauma Compared with Other Causes of Pediatric Traumatic Brain Injury.

Authors:  Laura S Blackwell; Margaret Martinez; Ashley Fournier-Goodnight; Janet Figueroa; Andrew Appert; Atul Vats; Bushra Wali; Iqbal Sayeed; Andrew Reisner
Journal:  J Pediatr       Date:  2020-07-02       Impact factor: 4.406

3.  Matrix Metalloproteinase 9 and Osteopontin Interact to Support Synaptogenesis in the Olfactory Bulb after Mild Traumatic Brain Injury.

Authors:  Melissa A Powell; Raiford T Black; Terry L Smith; Thomas M Reeves; Linda L Phillips
Journal:  J Neurotrauma       Date:  2019-01-10       Impact factor: 5.269

4.  Plasma osteopontin may predict neuroinflammation and the severity of pediatric traumatic brain injury.

Authors:  Ning Gao; Xiaohui Zhang-Brotzge; Bushra Wali; Iqbal Sayeed; Joshua J Chern; Laura S Blackwell; Chia-Yi Kuan; Andrew Reisner
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-13       Impact factor: 6.200

5.  Osteopontin in Vascular Disease.

Authors:  Zoe Shin Yee Lok; Alicia N Lyle
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-04       Impact factor: 8.311

Review 6.  Extracellular matrix and traumatic brain injury.

Authors:  Naijil George; Herbert M Geller
Journal:  J Neurosci Res       Date:  2018-01-18       Impact factor: 4.164

7.  Multi-Dimensional Mapping of Brain-Derived Extracellular Vesicle MicroRNA Biomarker for Traumatic Brain Injury Diagnostics.

Authors:  Jina Ko; Matthew Hemphill; Zijian Yang; Kryshawna Beard; Emily Sewell; Jamie Shallcross; Melissa Schweizer; Danielle K Sandsmark; Ramon Diaz-Arrastia; Junhyong Kim; David Meaney; David Issadore
Journal:  J Neurotrauma       Date:  2019-05-06       Impact factor: 4.869

8.  Activation of Alpha 7 Cholinergic Nicotinic Receptors Reduce Blood-Brain Barrier Permeability following Experimental Traumatic Brain Injury.

Authors:  Pramod K Dash; Jing Zhao; Nobuhide Kobori; John B Redell; Michael J Hylin; Kimberly N Hood; Anthony N Moore
Journal:  J Neurosci       Date:  2016-03-02       Impact factor: 6.167

9.  Repetitive Mild Traumatic Brain Injury and Transcription Factor Modulation.

Authors:  Whitney A Ratliff; Doaa Qubty; Vedad Delic; Chaim G Pick; Bruce A Citron
Journal:  J Neurotrauma       Date:  2020-05-04       Impact factor: 5.269

10.  A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.

Authors:  Altan Rentsendorj; Julia Sheyn; Dieu-Trang Fuchs; David Daley; Brenda C Salumbides; Hannah E Schubloom; Nadav J Hart; Songlin Li; Eric Y Hayden; David B Teplow; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.